Markets:

Overview

News

Currencies

International

Treasuries

RAPT Therapeutics, Inc. - Common Stock (NQ:RAPT)

58.02 UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about RAPT Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

RAPT Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From RAPT Therapeutics, Inc.

Via GlobeNewswire

RAPT Therapeutics Presents Update from its Phase 1/2 Clinical Trial for FLX475 as Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Cancer

December 08, 2022

Data Presented at ESMO Immuno-Oncology Congress

From RAPT Therapeutics, Inc.

Via GlobeNewswire

4 Analysts Have This to Say About RAPT Therapeutics ↗

December 01, 2022

Via Benzinga

RAPT Therapeutics to Present FLX475 Phase 1/2 Data at the European Society for Medical Oncology (ESMO) Immuno-Oncology Annual Congress

November 30, 2022

From RAPT Therapeutics, Inc.

Via GlobeNewswire

Expert Ratings For RAPT Therapeutics ↗

August 12, 2022

RAPT Therapeutics (NASDAQ:RAPT) has observed the following analyst ratings within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022 ↗

December 01, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 18, 2022

Via Benzinga

Delta Apparel, Farfetch, American Software And Some Other Big Stocks Moving Lower On Friday ↗

November 18, 2022

U.S. stocks traded mixed, with the Dow Jones gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Recap: RAPT Therapeutics Q2 Earnings ↗

August 11, 2022

RAPT Therapeutics (NASDAQ:RAPT) reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

This Mid-Cap Firm Can Potentially Offer Biggest Oral Drug In Atopic Dermatitis, Cantor Thinks So ↗

May 25, 2022

Via Benzinga

Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday ↗

November 21, 2022

Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 18, 2022

Via Benzinga

Recap: RAPT Therapeutics Q1 Earnings ↗

May 11, 2022

RAPT Therapeutics (NASDAQ:RAPT) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

RAPT Therapeutics Announces Pricing of Public Offering of Common Stock

November 17, 2022

From RAPT Therapeutics, Inc.

Via GlobeNewswire

RAPT Therapeutics Announces Proposed Public Offering of Common Stock

November 17, 2022

From RAPT Therapeutics, Inc.

Via GlobeNewswire

MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences ↗

November 14, 2022

BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares...

Via Benzinga

Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗

November 11, 2022

Gainers

Via Benzinga

RAPT Therapeutics Reports Third Quarter 2022 Financial Results

November 10, 2022

Company maintains strong cash position of $195.4 million

From RAPT Therapeutics, Inc.

Via GlobeNewswire

RAPT Therapeutics to Participate in Several Upcoming Investor Conferences

November 09, 2022

From RAPT Therapeutics, Inc.

Via GlobeNewswire

RAPT Therapeutics Strengthens Leadership Team with Two New Key Hires

September 28, 2022

From RAPT Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 24, 2022

Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares moved upwards by 20.1% to $1.79 during Wednesday's after-market session. The market value of their outstanding shares is at $31.6 million.

Via Benzinga

Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session ↗

August 12, 2022

Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.

Via Benzinga

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday ↗

August 15, 2022

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for RAPT Therapeutics: Here's What You Need To Know ↗

August 12, 2022

HC Wainwright & Co. has decided to maintain its Buy rating of RAPT Therapeutics (NASDAQ:RAPT) and raise its price target from $50.00 to $53.00. Shares of RAPT Therapeutics are trading up 14.98% over...

Via Benzinga

LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday ↗

August 12, 2022

WeTrade Group, Inc. (NASDAQ: WETG) jumped 46% to $20.56 after the company announced it entered into a sales agreement with Parkway Medical Limited to sell monkeypox virus test kits and antigen tests...

Via Benzinga

What 4 Analyst Ratings Have To Say About RAPT Therapeutics ↗

May 24, 2022

Analysts have provided the following ratings for RAPT Therapeutics (NASDAQ:RAPT) within the last quarter:

Via Benzinga

Starbucks And 2 Other Stocks Insiders Are Buying ↗

May 13, 2022

Although the Dow Jones jumped by more than 400 points on Friday, there were a few notable insider trades.

Via Benzinga

RAPT Therapeutics's Return On Capital Employed Insights ↗

March 14, 2022

According to Benzinga Pro data, during Q4, RAPT Therapeutics (NASDAQ:RAPT) posted sales of $756.00 thousand. Earnings were up 3.87%, but RAPT Therapeutics still reported an...

Via Benzinga

This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday ↗

July 29, 2022

Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 04, 2022

During Wednesday's trading, 435 companies set new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.